Oakworth Capital, Inc. Zynerba Pharmaceuticals, Inc. Transaction History

Oakworth Capital, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Aug 02, 2019	SELL	$5.4 - $15.5 $10,611 - $30,457	-1,965 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$3.6 - $6.22 $7,074 - $12,222	1,965 New	1,965 $11,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Oakworth Capital, Inc. with notifications on news.